Clover Health Investments (CLOV) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CLOV Stock Forecast

Clover Health Investments stock forecast is as follows: an average price target of $2.15 (represents a -35.82% downside from CLOV’s last price of $3.35) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.

CLOV Price Target

The average price target for Clover Health Investments (CLOV) is $2.15 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $2.50 to $1.80. This represents a potential -35.82% downside from CLOV's last price of $3.35.

CLOV Analyst Ratings

Hold

According to 5 Wall Street analysts, Clover Health Investments's rating consensus is 'Hold'. The analyst rating breakdown for CLOV stock is 0 'Strong Buy' (0.00%), 1 'Buy' (20.00%), 4 'Hold' (80.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Clover Health Investments Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 06, 2024	Richard Close	Canaccord Genuity	$2.50	$1.86	34.32%	-25.37%
Nov 16, 2022	-	Citigroup	$1.80	$1.44	25.00%	-46.27%

Row per page

Go to

The latest Clover Health Investments stock forecast, released on Aug 06, 2024 by Richard Close from Canaccord Genuity, set a price target of $2.50, which represents a 34.32% increase from the stock price at the time of the forecast ($1.86), and a -25.37% decrease from CLOV last price ($3.35).

Clover Health Investments Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$2.50
Last Closing Price	$3.35	$3.35	$3.35
Upside/Downside	-100.00%	-100.00%	-25.37%

In the current month, the average price target of Clover Health Investments stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Clover Health Investments's last price of $3.35. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 07, 2024	UBS	-	Neutral	Initialise
Aug 06, 2024	Canaccord Genuity	Buy	Buy	Hold
Nov 16, 2022	Citigroup	Neutral	Neutral	Hold
Aug 09, 2022	Citigroup	Neutral	Neutral	Hold
Aug 09, 2022	Credit Suisse	Underperform	Underperform	Hold
May 10, 2022	SVB Leerink	Market Perform	Market Perform	Hold
May 10, 2022	Cowen & Co.	Market Perform	Market Perform	Hold
Feb 25, 2022	SVB Leerink	Market Perform	Market Perform	Hold

Row per page

Go to

Clover Health Investments's last stock rating was published by UBS on Oct 07, 2024. The company Initialise its CLOV rating from "null" to "Neutral".

Clover Health Investments Financial Forecast

Clover Health Investments Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$510.25M	$482.07M	-	$527.77M	$898.79M	$856.82M	$846.70M	$874.38M	$432.04M	$427.16M	$412.47M	$200.32M	$-506.65M
Avg Forecast	$510.93M	$478.13M	$505.61M	$487.09M	$406.35M	$391.95M	$411.47M	$404.08M	$348.04M	$346.28M	$338.76M	$321.23M	$474.01M	$494.59M	$490.82M	$498.73M	$785.48M	$799.47M	$814.61M	$787.43M	$408.13M	$413.10M	$205.39M	$192.59M	$166.96M
High Forecast	$517.93M	$484.68M	$512.54M	$493.77M	$411.92M	$397.32M	$417.11M	$409.62M	$352.81M	$348.70M	$338.76M	$321.23M	$480.51M	$495.16M	$497.55M	$505.57M	$796.24M	$799.47M	$814.61M	$787.43M	$408.13M	$413.10M	$205.39M	$192.59M	$166.96M
Low Forecast	$504.57M	$472.18M	$499.32M	$481.03M	$401.29M	$387.07M	$406.35M	$399.05M	$343.71M	$343.85M	$338.76M	$321.23M	$468.11M	$494.02M	$484.71M	$492.52M	$775.70M	$799.47M	$814.61M	$787.43M	$408.13M	$413.10M	$205.39M	$192.59M	$166.96M
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.08%	0.97%	-	1.06%	1.14%	1.07%	1.04%	1.11%	1.06%	1.03%	2.01%	1.04%	-3.03%

Clover Health Investments's average Quarter revenue forecast for Mar 24 based on 1 analysts is $321.23M, with a low forecast of $321.23M, and a high forecast of $321.23M. CLOV's average Quarter revenue forecast represents a -37.05% decrease compared to the company's last Quarter revenue of $510.25M (Dec 23).

Clover Health Investments EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-64.99M	$-40.91M	-	$-72.33M	$-107.16M	$-73.30M	$-101.96M	$-86.47M	$-185.94M	$-33.98M	$-316.26M	$-33.42M	$20.01M
Avg Forecast	$-112.37M	$-105.16M	$-111.20M	$-107.13M	$-89.37M	$-86.20M	$-90.50M	$-88.87M	$-76.55M	$-76.16M	$-74.51M	$-83.95M	$-104.25M	$-108.78M	$-107.95M	$-89.79M	$-161.56M	$-185.33M	$-188.84M	$-96.03M	$-94.61M	$-95.76M	$-204.64M	$-44.65M	$-38.70M
High Forecast	$-110.97M	$-103.85M	$-109.82M	$-105.80M	$-88.26M	$-85.13M	$-89.37M	$-87.77M	$-75.59M	$-75.62M	$-74.51M	$-67.16M	$-102.95M	$-108.65M	$-106.61M	$-71.83M	$-129.25M	$-185.33M	$-188.84M	$-76.82M	$-94.61M	$-95.76M	$-163.71M	$-44.65M	$-38.70M
Low Forecast	$-113.91M	$-106.60M	$-112.73M	$-108.60M	$-90.60M	$-87.39M	$-91.74M	$-90.09M	$-77.60M	$-76.69M	$-74.51M	$-100.74M	$-105.68M	$-108.90M	$-109.43M	$-107.75M	$-193.87M	$-185.33M	$-188.84M	$-115.24M	$-94.61M	$-95.76M	$-245.56M	$-44.65M	$-38.70M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.62%	0.38%	-	0.81%	0.66%	0.40%	0.54%	0.90%	1.97%	0.35%	1.55%	0.75%	-0.52%

1 analysts predict CLOV's average Quarter EBITDA for Mar 21 to be $-44.65M, with a high of $-44.65M and a low of $-44.65M. This is -323.11% lower than Clover Health Investments's previous annual EBITDA (Dec 20) of $20.01M.

Clover Health Investments Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-41.47M	-	$-72.61M	$-61.63M	$-76.29M	$-105.41M	$-62.91M	$-187.61M	$-34.53M	$-317.61M	$-48.42M	$3.26M
Avg Forecast	$-28.33M	$-3.72M	$-3.00M	$-8.52M	$-29.41M	$-11.28M	$-4.73M	$-21.99M	$-33.31M	$-20.06M	$-23.79M	$-85.34M	$-68.33M	$-51.76M	$-68.01M	$-91.28M	$-162.66M	$-109.33M	$-96.02M	$-97.62M	$-126.04M	$-111.48M	$-205.51M	$-53.29M	$-416.81M
High Forecast	$-27.88M	$-3.66M	$-2.96M	$-8.38M	$-28.93M	$-11.10M	$-4.65M	$-21.64M	$-32.77M	$-19.74M	$-23.40M	$-68.28M	$-67.22M	$-50.92M	$-66.90M	$-73.02M	$-130.13M	$-109.33M	$-96.02M	$-78.10M	$-126.04M	$-111.48M	$-164.41M	$-53.29M	$-416.81M
Low Forecast	$-28.84M	$-3.78M	$-3.06M	$-8.67M	$-29.93M	$-11.48M	$-4.81M	$-22.39M	$-33.90M	$-20.42M	$-24.21M	$-102.41M	$-69.55M	$-52.68M	$-69.22M	$-109.53M	$-195.19M	$-109.33M	$-96.02M	$-117.15M	$-126.04M	$-111.48M	$-246.62M	$-53.29M	$-416.81M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.80%	-	0.80%	0.38%	0.70%	1.10%	0.64%	1.49%	0.31%	1.55%	0.91%	-0.01%

Clover Health Investments's average Quarter net income forecast for Mar 21 is $-53.29M, with a range of $-53.29M to $-53.29M. CLOV's average Quarter net income forecast represents a -1736.64% decrease compared to the company's last Quarter net income of $3.26M (Dec 20).

Clover Health Investments SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$45.98M	$41.75M	-	$129.42M	$124.35M	$117.97M	$117.53M	$126.79M	$114.21M	$119.11M	$107.80M	$104.63M	$54.56M
Avg Forecast	$138.11M	$129.25M	$136.68M	$131.67M	$109.84M	$105.95M	$111.23M	$109.23M	$94.08M	$93.60M	$91.57M	$143.68M	$128.13M	$133.70M	$132.68M	$153.67M	$99.23M	$216.19M	$220.29M	$164.35M	$110.37M	$111.71M	$69.75M	$52.08M	$45.15M
High Forecast	$140.01M	$131.02M	$138.55M	$133.47M	$111.35M	$107.40M	$112.75M	$110.73M	$95.37M	$94.26M	$91.57M	$172.42M	$129.89M	$133.85M	$134.50M	$184.41M	$119.08M	$216.19M	$220.29M	$197.23M	$110.37M	$111.71M	$83.70M	$52.08M	$45.15M
Low Forecast	$136.39M	$127.64M	$134.97M	$130.03M	$108.48M	$104.63M	$109.84M	$107.87M	$92.91M	$92.95M	$91.57M	$114.95M	$126.54M	$133.54M	$131.03M	$122.94M	$79.39M	$216.19M	$220.29M	$131.48M	$110.37M	$111.71M	$55.80M	$52.08M	$45.15M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.36%	0.31%	-	0.84%	1.25%	0.55%	0.53%	0.77%	1.03%	1.07%	1.55%	2.01%	1.21%

Clover Health Investments's average Quarter SG&A projection for Mar 24 is $143.68M, based on 1 Wall Street analysts, with a range of $114.95M to $172.42M. The forecast indicates a 212.47% rise compared to CLOV last annual SG&A of $45.98M (Dec 23).

Clover Health Investments EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.09	-	$-0.15	$-0.13	$-0.16	$-0.22	$-0.13	$-0.40	$-0.08	$-0.78	$-0.13	$-0.20
Avg Forecast	$-0.06	$-0.01	$-0.01	$-0.02	$-0.06	$-0.02	$-0.01	$-0.04	$-0.07	$-0.04	$-0.05	$-0.07	$-0.14	$-0.11	$-0.14	$-0.17	$-0.24	$-0.22	$-0.20	$-0.27	$-0.26	$-0.23	$-0.14	$-0.11	$-0.86
High Forecast	$-0.06	$-0.01	$-0.01	$-0.02	$-0.06	$-0.02	$-0.01	$-0.04	$-0.07	$-0.04	$-0.05	$-0.07	$-0.14	$-0.10	$-0.14	$-0.16	$-0.24	$-0.22	$-0.20	$-0.27	$-0.26	$-0.23	$-0.14	$-0.11	$-0.86
Low Forecast	$-0.06	$-0.01	$-0.01	$-0.02	$-0.06	$-0.02	$-0.01	$-0.05	$-0.07	$-0.04	$-0.05	$-0.07	$-0.14	$-0.11	$-0.14	$-0.17	$-0.24	$-0.22	$-0.20	$-0.27	$-0.26	$-0.23	$-0.14	$-0.11	$-0.86
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.82%	-	0.90%	0.54%	0.71%	1.12%	0.48%	1.55%	0.36%	5.69%	1.19%	0.24%

According to undefined Wall Street analysts, Clover Health Investments's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CLOV previous annual EPS of $NaN (undefined).

Clover Health Investments Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
SKLZ	Skillz	$5.04	$1.40K	27717.46%	Hold
FUBO	fuboTV	$1.44	$5.29	267.36%	Buy
SNDL	SNDL	$1.96	$3.95	101.53%	Hold
BB	BlackBerry	$2.31	$4.18	80.95%	Buy
CLOV	Clover Health Investments	$3.35	$2.15	-35.82%	Hold
WISH	ContextLogic	$5.13	$2.00	-61.01%	Hold

CLOV Forecast FAQ

Is Clover Health Investments a good buy?

No, according to 5 Wall Street analysts, Clover Health Investments (CLOV) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 20.00% of CLOV's total ratings.

What is CLOV's price target?

Clover Health Investments (CLOV) average price target is $2.15 with a range of $1.8 to $2.5, implying a -35.82% from its last price of $3.35. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Clover Health Investments stock go up soon?

According to Wall Street analysts' prediction for CLOV stock, the company can go down by -35.82% (from the last price of $3.35 to the average price target of $2.15), down by -25.37% based on the highest stock price target, and down by -46.27% based on the lowest stock price target.

Can Clover Health Investments stock reach $5?

CLOV's average twelve months analyst stock price target of $2.15 does not support the claim that Clover Health Investments can reach $5 in the near future.

What are Clover Health Investments's analysts' financial forecasts?

Clover Health Investments's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.61B (high $1.64B, low $1.59B), average EBITDA is $-355M (high $-351M, low $-360M), average net income is $-67.409M (high $-66.318M, low $-68.61M), average SG&A $436.26M (high $442.24M, low $430.82M), and average EPS is $-0.138 (high $-0.135, low $-0.14). CLOV's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.98B (high $2.01B, low $1.96B), average EBITDA is $-436M (high $-430M, low $-442M), average net income is $-43.576M (high $-42.87M, low $-44.352M), average SG&A $535.71M (high $543.05M, low $529.04M), and average EPS is $-0.0889 (high $-0.0875, low $-0.0905).

Did the CLOV's actual financial results beat the analysts' financial forecasts?

Based on Clover Health Investments's last annual report (Dec 2023), the company's revenue was $2.03B, beating the average analysts forecast of $1.96B by 3.86%. Apple's EBITDA was $-206M, missing the average prediction of $-411M by -49.84%. The company's net income was $-213M, missing the average estimation of $-279M by -23.63%. Apple's SG&A was $187.57M, missing the average forecast of $548.18M by -65.78%. Lastly, the company's EPS was $-0.44, missing the average prediction of $-0.55 by -20.03%. In terms of the last quarterly report (Dec 2023), Clover Health Investments's revenue was $510.25M, beating the average analysts' forecast of $474.01M by 7.65%. The company's EBITDA was $-64.986M, missing the average prediction of $-104M by -37.66%. Clover Health Investments's net income was $0, missing the average estimation of $-68.331M by -100.00%. The company's SG&A was $45.98M, missing the average forecast of $128.13M by -64.11%. Lastly, the company's EPS was $0, missing the average prediction of $-0.139 by -100.00%